Botswana-Harvard Partnership Strategic Plan Review

Botswana-Harvard Partnership, 2014

In 2010, the Botswana Harvard Partnership (BHP) underwent a Strategic Planning process and created a strategic plan for the years 2011 – 2016. Strategic themes of Research Excellence, Education and Capacity Building and Organizational Excellence were identified. This report is the three year review of the status of this Strategic Plan, as of 2014.   Read The Report …



ACHAP Annual Report, 2014

ACHAP Report 20142014 marked the last steps before the new ACHAP could fully rise and take steps into Africa. It was the conclusion of the five-year support grant, a phase during which ACHAP was funded exclusively by the Merck Company Foundation and the Bill and Melinda Gates Foundation. During this time key focus support areas for ACHAP were Safe Male Circumcision (SMC), TB/HIV Integration and HIV/AIDS Treatment Transition and Support. In 2014 ACHAP’s main concern was to responsibly bring to an end its involvement in the programs it had started during this phase and transitioning them over to the Government of Botswana. Having been extremely successful and effective under ACHAP it was now time for the primary stakeholders to take ownership and begin a new chapter where the sustainability and longevity of the programs will be paramount.   Read The Report

ACHAP Annual Report, 2013

The African Comprehensive HIV/AIDS Partnership (ACHAP)

Mission: To provide comprehensive, innovative and catalytic solutions through Public Private Community Partnerships (PPCP) to achieve sustainable population health.

  • ACHAP supported Safe Male Circumcision (SMC) teams performed 35,507 circumcisions by December 31st 2013, which represented about 71 % of Botswana’s Annual national target. ACHAP’s cost per SMC dropped to an average of USD$98 in 2013 from USD$179 in 2011. SMC campaigns conducted by ACHAP show modern medical practices can successfully be blended with traditional practices with impressive results.
  • HIV testing amongst TB patients in ACHAP supported districts is estimated at 99%. The 2013-2017 National TB Advocacy Communication and Social Mobilization Strategy and training curriculum for implementers was finalized in the year under review.
  • In November 2013, 197,109 patients were on AntiRetroviral Treatment (ART) in the public sector with a combined cumulative total of 228, 195 patients on ART nationwide. The “Treatment Optimization Pilot” project increased access to HIV Counseling and Testing services (over 60% new testers) and CD4 testing, with reduction in delays to ART initiation.
  • The Sesigo project was launched in 2011 with 62 library staff qualifying for ICDL certification. Public training continues to take place at the public libraries, with 3578 trained during the reporting period bringing the total number of people trained to 59,867.   Read The Report

Project HEART – End of Project Report

Elizabeth Glaser Pediatric AIDS Foundation, 2012

Through the leadership and support of the President’s Emergency Plan for AIDS Relief (PEPFAR) and the U.S. Centers for Disease Control and Prevention, the Elizabeth Glaser Pediatric AIDS Foundation is honored to have led Project HEART (Help Expand Antiretroviral Therapy to children and families), an eight-year initiative to extend life-saving treatment to millions of people living with HIV. Project HEART was part of the PEPFAR Track 1.0 treatment initiative to rapidly scale up antiretroviral therapy (ART) through existing organizations implementing prevention of mother-to-child transmission of HIV (PMTCT) programs. Project HEART was launched in 2004 in Côte d’Ivoire, South Africa, Tanzania, and Zambia, and in 2006 in Mozambique. Through the project, more than 1 million men, women, and children received HIV care and support, more than 2.5 million pregnant women received HIV counseling and testing, and more than half a million people started ART. In 2010, 1 out of every 10 PEPFAR-supported ART patients in sub-Saharan Africa received their treatment through Project HEART.  Read The Report

Transitioning Large-Scale HIV Care and Treatment Programs to Sustainable National Ownership

The Project HEART Experience

The rapid scale up of life-saving HIV care and treatment services has been a public health success. To date, the U.S. Government–funded rapid HIV program scale up efforts in resource-limited settings have been implemented mostly through funding international nongovernmental organizations (NGOs). Over the past few years, funding priorities for the global health and development community have shifted from an emergency response to local ownership and longer-term health systems strengthening. The expectation is that host country governments and local NGOs fully own and manage implementation of their HIV care and treatment services.  Read The Report

Engaging to End the Epidemic: Seven Essential Steps Toward an AIDS-Free Generation

JAIDS SupplementalA special supplement of the Journal of Acquired Immune Deficiency Syndromes, August 1, 2012, Vol.60 Supplement 2

Over the past three decades, nearly 30 million people have lost their lives to AIDS and the epidemic has transformed communities around the world. Today, an estimated 34 million people are living with HIV. The number of people affected leaves no doubt: AIDS remains an urgent global health crisis.

Despite these sobering facts, recent advancements have provided unprecedented hope for an end to the epidemic. A rapid scale-up of antiretroviral therapy and prevention efforts has saved millions of lives. In many of the hardest-hit countries, in certain settings, the rate of new infections is decreasing. The number of AIDS-related deaths is also on a consistent downward slope. Most notably, new research has definitively shown that antiretroviral therapy can prevent new infections. These historic developments, along with many local and national achievements, have changed the global conversation about the epidemic.

The end of AIDS is within our reach. The question that remains is how will we get there.  Read The Special Supplement

Models of Care Final Report, 2012

In Botswana, about 25% of adults have HIV. In 2001, the government showed extraordinary vision in deciding to provide antiretroviral (ARV) medication to all in need. The national HIV/AIDS treatment plan was created, scaled-up, and continues to provide life-saving ARVs today. Questions that always need to be asked about ambitious government programs are, how well is it working and what does it cost?

The Models of Care project was designed to provide answers. From 2007 to 2011, researchers led by the Harvard AIDS Initiative’s Executive Director, Dr. Richard Marlink, examined the costs and effectiveness of the Botswana National Antiretroviral Treatment Program. Collaborating with the Botswana – Harvard AIDS Institute Partnership (BHP), the Botswana Ministry of Health, and the African Comprehensive HIV/AIDS Partnerships (ACHAP), The Models of Care program consisted of three study arms:

1. Evaluation of the program at the individual patient level
2. Costing of the program over time
3. Creation of specific clinical cohorts to answer Botswana-specific care and treatment questions

The Models of Care researchers issued their final report, with study results, analysis, and specific recommendations. The report serves to inform the debate regarding the efficacy, financial sustainability, feasibility, and effectiveness of existing models of clinical healthcare delivery and laboratory monitoring in Botswana.  Read The Report

AIDS@30 Symposium

Harvard School of Public Health, Dec 2011

AIDS@30 LogoTo commemorate the 30th anniversary of AIDS, Harvard University convened a major international symposium. The vanguard of the global AIDS response gathered December 1-2, 2011, to reflect on what we have learned from AIDS and how to apply those lessons towards ending the epidemic.

Welcome Message to the symposium from Richard Marlink:

Explore the conversation and learn about the outcomes from AIDS@30, hosted by the Harvard School of Public Health.

To learn more about AIDS@30 Symposium: 
The Program
The Outcomes

The Enhancing Care Initiative: AIDS Care Teams in Action

The Enhancing Care Initiative, 1998 – 2004

In 1998, Harvard University and the Merck Company Foundation initiated plans to establish the Enhancing Care Initiative (ECI) to improve the clinical care of people living with HIV/AIDS in resource-scarce settings. The key strength of the ECI was the multisectoral and multidisciplinary AIDS Care Teams that lead the analysis and the improvement of HIV/AIDS care, by designing locally appropriate solutions in challenging contexts, and generating new evidence and best practices that were applicable in diverse settings. Through the ECI, teams of local care experts based in São Paulo and Santos, Brazil, in Dakar, Senegal, in KwaZulu-Natal, South Africa, in Northern Thailand, and in Western Puerto Rico worked locally to address the problems in HIV/AIDS care in their specific communities and regions.  Read More

Collaborating to Improve HIV/AIDS Care & Treatment in Resource- Scare Settings
 How to Form & Sustain Effective AIDS Care Teams

The Enhancing Care Initiative, 1998 – 2004

This publication is an outgrowth of the work of the Enhancing Care Initiative. In the process of learning to work together, the members of the ECI AIDS Care Teams collectively accumulated important insights as to how to form and sustain effective care teams. Focusing on the process of working together across organizations and sectors, the purpose of this publication is to share the lessons learned about what we believe it takes to make these sorts of collaborations most effective, and to help make more sustainable improvements in the global response to HIV and AIDS. It is also intended to signal what issues people may anticipate in collaboration across organizations and sectors and what some possible courses of action might be.   Read More